WebGlycanostics, Ltd. Comenius University, Bratislava About We are Glycanostics! We are early cancer diagnostics revolution! "Where I am … WebAll day. 4 th - 8 th June, Boston, US In just few months, Glycanostics, Ltd. is going to attend a global biotechnology event in Boston, BIO International conference. As a part of EIC European Pavilion, our […] Find out more. 01 October 2024. Glycanostics is an innovative start-up company established in 2024 to take its … At Glycanostics, our aim is to develop, clinically validate & register an … At Glycanostics, we are developing highly innovative tests for the detection of … Glycanostics is an innovative start-up company developing diagnostic tests for … Glycanostics, Ltd. as a regional winner, was selected from more than 10 000 start … Contact Us - Glycanostics - Early stage, highly accurate and unique cancer … Supervisory Board - Glycanostics - Early stage, highly accurate and unique … At Glycanostics, we perceive it as our duty to make this innovation available to … Glycanostics is an innovative start-up company established in 2024 to deliver … Behind The Technology - Glycanostics - Early stage, highly accurate and unique …
Tomas Bertok, Ph.D. 🩸 Cancer DX - LinkedIn
WebOct 1, 2024 · I enjoyed being a part of Glycanostics team a lot.” Jan Tkac, PhD. 🥼 Cancer Diagnostics “👍 Tomas is the best student I have had a supervisor. He was the key … WebYesterday, Glycanostics, Ltd. hosted an important visit - 17 ambassadors from different countries from Asia, Europe, South America and USA. We talked about the problems of current diagnostics and ... formel 1 online stream
Jan Tkac, PhD. 🥼 Cancer Diagnostics’ Post - LinkedIn
WebGLYCANOSTICS SRO Slovakia . Project description. DE EN ES FR IT PL. A sensitive diagnostic for prostate cancer. The prostate-specific antigen (PSA) is currently used as a biomarker for prostate cancer. However, PSA tests lack diagnostic accuracy as they have a high false positive rate, leading to wrong treatments and unnecessary prostate ... WebJul 14, 2024 · Vedci z mladej slovenskej firmy Glycanostics sa usilujú o zásadnú novinku v diagnostike rakoviny prostaty. Vyvinuli testy na detekciu ochorenia na základe vyšetrenia krvi – bez potreby nepríjemného zákroku, teda biopsie. WebGlycanostics´s® test will separate healthy men from men at risk of prostate cancer, who need a confirmatory biopsy. It’s organ specific and it detects prostate cancer with 85-90% accuracy. It is... formel 1 power unit